SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-09-04 20:10
Tx date 2020-09-01
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Walewicz, Joseph Andrew
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
56 - Grant of rights
$5,437
+6,250 vol
$0.87 each
6,250
Filed 2020-09-04 20:09
Tx date 2020-06-25
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Walewicz, Joseph Andrew
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-04 20:08
Tx date 2020-09-01
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Walewicz, Joseph Andrew
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$16,312
+18,750 vol
$0.87 each
18,750
Filed 2020-09-04 20:06
Tx date 2020-06-25
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Walewicz, Joseph Andrew
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-22 10:35
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash

-191,720 vol
0
Filed 2019-02-21
Tx date 2019-02-18
$CMTA
Clementia Pharmaceuticals Inc.
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+27,800 vol
191,720
Filed 2018-04-20
Tx date 2018-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
163,920
Filed 2018-03-05
Tx date 2018-02-27
$CMTA
Clementia Pharmaceuticals Inc.
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+58,000 vol
153,920
Filed 2018-03-05
Tx date 2018-02-27
$CMTA
Clementia Pharmaceuticals Inc.
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
95,920